Overview

Understanding Cognition, Oxytocin & Pain in Elders

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Osteoarthritis (OA) represents a significant cause of disability worldwide and the knee is the most commonly affected joint. Oxytocin (OT) is a mediator of endogenous analgesia in animal and human studies. This proposal will test the efficacy and safety of self-administered intranasal OT over 4-weeks in older individuals relative to placebo (P) evaluating its effects on pain and function in aging and testing potential underlying neurobiological mechanisms.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Florida
Collaborator:
National Institute on Aging (NIA)
Treatments:
Oxytocin